LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that its Venezuelan operating affiliate, LataMed AI VE, will be featured in an interview in ES Salud Magazine, a healthcare-focused publication. The feature is expected to be published in the July 2026 edition and will include an editorial profile and interview discussing the Company’s healthcare technology initiatives, digital healthcare ecosystem strategy, and efforts to improve healthcare accessibility throughout Latin America.
According to the Company, the feature will cover its telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and artificial intelligence-driven healthcare solutions currently under development. The Company noted that it has received a formal invitation from the publisher to participate in a broader editorial feature package expected to include coverage through both ES Salud Magazine and Eva’s Magazine, distributed through multiple print, digital, social media, and online publication channels.
Management stated that this publication provides an opportunity to discuss LataMed AI’s evolving healthcare platform while increasing visibility among healthcare professionals, industry participants, and stakeholders. The feature is expected to highlight the Company’s broader vision of developing an integrated healthcare ecosystem designed to improve accessibility, coordination, and engagement for patients, healthcare providers, and other stakeholders across emerging markets.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We appreciate the opportunity to share our vision for technology-enabled healthcare solutions and discuss the initiatives we are currently advancing throughout Latin America. We believe healthcare accessibility, coordination, and patient engagement remain important challenges across many markets, and we welcome opportunities to participate in industry discussions regarding the role of technology in addressing those challenges.”
The Company expects the feature to be published during July 2026 and intends to provide additional updates once publication details are finalized, including information regarding publication dates, online availability, print distribution, and access through the publication's online digital channels. For additional information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This press release contains forward-looking statements regarding the Company's business strategy, industry engagement initiatives, healthcare technology initiatives, telehealth infrastructure development, artificial intelligence applications, commercialization initiatives, platform deployment, operational execution, strategic relationships, potential collaboration opportunities, market opportunities, regional expansion plans, and future operations. Actual results may differ materially due to various factors, including the Company's ability to successfully implement its business plan, availability of financing, regulatory authorizations, operational and technology deployment risks, risks associated with operations in emerging markets including Venezuela, and general economic and market conditions.
For investors, this feature represents a milestone in LataMed AI’s efforts to gain visibility in the healthcare sector. The broader industry impact lies in the potential for AI-driven telehealth solutions to address persistent challenges in healthcare accessibility and coordination in Latin America. As the Company continues to develop its platform, engagement with healthcare-focused publications may help attract partners and stakeholders interested in digital health innovation.
